The latest news from the global pharmaceutical industry. Below you will find news and information to keep you up-to-date with what is happening in your industry. Coverage includes regulatory approvals, recall announcements, mergers and acquisitions, personnel news and appointments, new facility and facility expansion updates, collaborations and agreements, and financial updates.
FDA is alerting patients, caregivers and health care professionals to immediately inspect certain lots of Amneal and Impax epinephrine auto-injector 0...
read more
Braeburn has requested final approval from the FDA of the NDA for BRIXADI weekly and monthly extended-release injection for the treatment of opioid ...
read more
RenovoRx announced the FDA has granted the Company orphan drug designation for treating bile duct cancer.
read more
Novartis has received notice from the FDA the agency has extended its review of the sBLA for ofatumumab, a self-administered, targeted B-cell therapy ...
read more
American Regent has announced the introduction and availability of Estradiol Valerate Injection, USP – AO Rated and therapeutically equivalent to ...
read more
Review the latest news and information on the Coronavirus Pandemic.
read more
Impel NeuroPharma announced positive results from the Company's Phase 3 study of the safety and tolerability of INP104 administered to the vascular ...
read more
Review the latest news and information on the Coronavirus Pandemic.
read more
Review the latest news and information on the Coronavirus Pandemic.
read more
The FDA has approved Lyumjev, Lilly's new rapid-acting insulin indicated to improve glycemic control in adults with type 1 and type 2 diabetes.
read more
The FDA has approved a 300 mg single-dose pre-filled pen for Dupixent (dupilumab).
read more
Companion Medical, manufacturers of InPen, the only FDA-cleared smart insulin pen system, has announced that they received FDA expanded clearance for ...
read more
IgNova has filed a patent application covering the use of passive immunization to control SARS-CoV-2 infection in humans.
read more
Novartis Pharma announced the Japanese Ministry of Health, Labour and Welfare approved five new treatment options for Japanese patients.
read more
Ardelyx announced the submission of an NDA for tenapanor to the FDA for the control of serum phosphorus in adult patients with chronic kidney disease ...
read more